Biblio

Weil D, Pan H-C, Levesque E, Sauneuf B, Theocharidou E, Cholongitas E, Karvellas CJ, Robert R, Galbois A, Fichet J et al..  2014.  Prognosis of cirrhotic patients admitted in Intensive care Unit: A Meta-analysis. HEPATOLOGY. 60:490A.

Weil D, Pan H-C, Levesque E, Sauneuf B, Theocharidou E, Cholongitas E, Karvellas CJ, Robert R, Galbois A, Fichet J et al..  2014.  Prognosis of cirrhotic patients admitted in Intensive care Unit: A Meta-analysis. HEPATOLOGY. 60:490A.

Weil D, Levesque E, McPhail M, Cavallazzi R, Theocharidou E, Cholongitas E, Galbois A, Pan HChih, Karvellas CJ, Sauneuf B et al..  2017.  Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis. ANNALS OF INTENSIVE CARE. 7:33.

Piton G, Chaignat C, Giabicani M, Cervoni J-P, Tamion F, Weiss E, Paugam-Burtz C, Capellier G, Di Martino V.  2016.  Prognosis of cirrhotic patients admitted to the general ICU. ANNALS OF INTENSIVE CARE. 6:94.

Chen K, Laghrouche S, Djerdir A.  2021.  Prognosis of fuel cell degradation under different applications using wavelet analysis and nonlinear autoregressive exogenous neural network. RENEWABLE ENERGY. 179:802-814.

Henriques J., Vernerey D., de Gramont A., Chibaudel B., Van Cutsem E., Falcone A., Goldberg R.M, Shi Q., Bonnetain F., Shmueli E..  2016.  Prognosis of lung metastases in patients with metastatic colorectal cancer: an ARCAD meta analysis. ANNALS OF ONCOLOGY. 27:122.

Henriques J., Vernerey D., de Gramont A., Chibaudel B., Van Cutsem E., Falcone A., Goldberg R.M, Shi Q., Bonnetain F., Shmueli E..  2016.  Prognosis of lung metastases in patients with metastatic colorectal cancer: an ARCAD meta analysis. ANNALS OF ONCOLOGY. 27:122.

Stamboul K, Zeller M, Fauchier L, Gudjoncik A, Buffet P, Garnier F, Guenancia C, Lorgis L, Beer JClaude, Touzery C et al..  2015.  Prognosis of silent atrial fibrillation after acute myocardial infarction at 1-year follow-up. HEART. 101:864-869.

Curtit E, Henriques J, Paget-Bailly S, Ladoire S, Darut-Jouve A, Debled M, Romieu G, Garnier-Tixidre C, Jacquin J-P, Soulie P et al..  2019.  Prognosis value of a genetic score based on germline genetic variants in a prospective cohort of early triple negative breast cancer patients. JOURNAL OF CLINICAL ONCOLOGY. 37

Kanoun S., Berriolo-Riedinger A., Tal I., Edeline V., Cottereau A., Brice P., Bouabdallah R., Salles G., Stamatoullas A., Dupuis J. et al..  2016.  Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 43:S125-S126.

Kanoun S., Berriolo-Riedinger A., Tal I., Edeline V., Cottereau A., Brice P., Bouabdallah R., Salles G., Stamatoullas A., Dupuis J. et al..  2016.  Prognosis value of baseline total metabolic tumor volume (TMTV) in advanced Hodgkin lymphoma (HL) : Ancillary study of AHL2011 LYSA trial. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 43:S125-S126.

Bailly E., Proust B., Chabot V., Giral M., Vuiblet V., Chatelet V., Morelon E., Malvezzi P., Caillard S., Barrou B. et al..  2016.  PROGNOSIS VALUE OF C1Q BINDING ANTI-HLA ANTIBODIES IN ACUTE ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANTATION. TRANSPLANT INTERNATIONAL. 29:17.

Ellouze O, Nguyen M, Missaoui A, Berthoud V, Aho S, Bouchot O, Guinot PGregoire, Bouhemad B.  2020.  Prognosis Value of Early Veno Arterial PCO2 Difference in Patients Under Peripheral Veno Arterial Extracorporeal Membrane Oxygenation. SHOCK. 54:744-750.

Bailly C., Carlier T., Meignan M., C. Crepin G, A. Riedinger B, Devillers A., F. Bodere K, Le Gouill S., C. Milin B.  2016.  Prognosis value of FDG-PET Parameters at Diagnosis and after Induction in Patients with Mantle Cell Lymphoma, Interim Results from the LyMa-PET Project, a LYSA study. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 43:S202.

Bodet-Milin C, Bailly C, Meignan M, Berriolo-Riedinger A, Devillers A, Hermine O, Carlier T, Hatt M, Kraeber-Bodere F, Le Gouill S.  2015.  Prognosis value of quantitative indices derived from initial FDG PET/CT in untreated mantle cell lymphoma patients enrolled in the Lyma trial, a LYSA study. Preliminary results.. JOURNAL OF NUCLEAR MEDICINE. 56

Bailly E., Proust B., Giral M., Vuiblet V., Chatelet V., Morelon E., Malvezzi P., Caillard S., Barrou B., Couzi L. et al..  2016.  Prognosis Value of the Presence and Persistence of C1q Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.. AMERICAN JOURNAL OF TRANSPLANTATION. 16:605.

Freund Y, Lemachatti N, Krastinova E, Van Laer M, Claessens Y-E, Avondo A, Occelli C, Feral-Pierssens A-L, Truchot J, Ortega M et al..  2017.  Prognostic Accuracy of Sepsis-3 Criteria for In-Hospital Mortality Among Patients With Suspected Infection Presenting to the Emergency Department. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 317:301-308.

Curtit E., Mansi L., Maisonnette-Escot Y., Sautiere J.-L, Pivot X..  2017.  Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX (R) Breast Recurrence Score Assay. EJSO. 43:921-930.

Fumet J-D, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagne A, Hamel M-A, Guimaraes CFigueiredo et al..  2019.  Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy (vol 119, pg 950, 2018). BRITISH JOURNAL OF CANCER. 121:283.

Fumet J-D, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagne A, Hamel M-A, Guimaraes CFigueiredo et al..  2018.  Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy. BRITISH JOURNAL OF CANCER. 119:950-960.

Pages F., Andre T., Taieb J., Vernerey D., Henriques J., Borg C., Marliot F., Ben Jannet R., Louvet C., Mineur L. et al..  2020.  Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study y. ANNALS OF ONCOLOGY. 31:921-929.

Pages F., Andre T., Taieb J., Vernerey D., Henriques J., Borg C., Marliot F., Ben Jannet R., Louvet C., Mineur L. et al..  2020.  Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study (vol 31, pg 921, 2020). ANNALS OF ONCOLOGY. 31:1276.

Pages F, Andre T, Taieb J, Vernerey D, Henriques J, Borg C, Marliot F, Ben Jannet R, Louvet C, Mineur L et al..  2020.  Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with mFOLFOX6 (three versus six months) in the prospective IDEA France cohort study (PRODIGE-GERCOR).. JOURNAL OF CLINICAL ONCOLOGY. 38

Tauziede-Espariat A., Beccaria K., Monnieni F., Adle-Biassette H., Masliah-Planchon J., Polivka M., Laquerriere A., Bouillot-Eimer S., Gauchotte G., Sevestre H. et al..  2016.  Prognostic and therapeutic biomarkers in a series of 33 pediatric chordomas. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 42:19.

Tauziede-Espariat A., Beccaria K., Monnieni F., Adle-Biassette H., Masliah-Planchon J., Polivka M., Laquerriere A., Bouillot-Eimer S., Gauchotte G., Sevestre H. et al..  2016.  Prognostic and therapeutic biomarkers in a series of 33 pediatric chordomas. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 42:19.